Still debating a cause and diagnostic criteria for Alzheimer's disease.
作者信息
Popescu Bogdan O
出版信息
J Cell Mol Med. 2007 Nov-Dec;11(6):1225-6. doi: 10.1111/j.1582-4934.2007.00149.x. Epub 2007 Nov 20.
Abstract
摘要
相似文献
1
Still debating a cause and diagnostic criteria for Alzheimer's disease.仍在探讨阿尔茨海默病的病因及诊断标准。
J Cell Mol Med. 2007 Nov-Dec;11(6):1225-6. doi: 10.1111/j.1582-4934.2007.00149.x. Epub 2007 Nov 20.
2
Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.致力于开发针对阿尔茨海默病淀粉样蛋白和tau蛋白病变的药物。
Int J Geriatr Psychiatry. 2011 May;26(5):546-8. doi: 10.1002/gps.2543.
3
Current understanding of Alzheimer's disease diagnosis and treatment.阿尔茨海默病诊断与治疗的当前认识
F1000Res. 2018 Jul 31;7. doi: 10.12688/f1000research.14506.1. eCollection 2018.
4
Alzheimer's disease-do tauists and baptists finally shake hands?阿尔茨海默病——tau蛋白研究者和淀粉样蛋白研究者终于握手言和了吗？
Trends Neurosci. 2002 Jan;25(1):22-6. doi: 10.1016/s0166-2236(00)02031-2.
5
Understanding the cause of sporadic Alzheimer's disease.了解散发性阿尔茨海默病的病因。
Expert Rev Neurother. 2014 Jun;14(6):621-30. doi: 10.1586/14737175.2014.915740.
6
Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.阿尔茨海默病综述：抑制淀粉样β和tau 缠结形成。
Int J Biol Macromol. 2021 Jan 15;167:382-394. doi: 10.1016/j.ijbiomac.2020.11.192. Epub 2020 Dec 2.
7
Untangling the relation between beta-amyloid and tau.理清β-淀粉样蛋白与tau蛋白之间的关系。
Lancet. 2001 Aug 25;358(9282):645. doi: 10.1016/S0140-6736(01)05825-1.
8
Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection.阿尔茨海默病中的β淀粉样蛋白、tau蛋白和载脂蛋白E4：轴突连接
Trends Mol Med. 2007 Apr;13(4):135-42. doi: 10.1016/j.molmed.2007.02.004. Epub 2007 Mar 6.
9
The Prion-like Properties of Amyloid-beta Peptide and Tau: Is there Any Risk of Transmitting Alzheimer's Disease During Neurosurgical Interventions?淀粉样β肽和 Tau 的朊病毒样特性：在神经外科手术干预过程中是否存在传播阿尔茨海默病的风险？
Curr Alzheimer Res. 2020;17(9):781-789. doi: 10.2174/1567205017666201204164220.
10
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.β淀粉样蛋白和 tau--阿尔茨海默病中的毒性双人舞。
Nat Rev Neurosci. 2011 Feb;12(2):65-72. doi: 10.1038/nrn2967. Epub 2010 Dec 31.
引用本文的文献
1
Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation.通过时飞磁共振血管造影术测量胆固醇喂养的伴有皮质淀粉样β肽积累的兔的神经血管变化。
J Magn Reson Imaging. 2010 Aug;32(2):306-14. doi: 10.1002/jmri.22244.
2
Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.阿尔茨海默病淀粉样前体蛋白/早老素 1 小鼠模型中活性依赖性神经保护蛋白 (ADNP) 的表达。
J Mol Neurosci. 2010 May;41(1):114-20. doi: 10.1007/s12031-009-9300-x. Epub 2009 Oct 21.
3
Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.基因组时代之后的阿尔茨海默病：基于核磁共振波谱的代谢组学
J Cell Mol Med. 2008 Sep-Oct;12(5A):1477-85. doi: 10.1111/j.1582-4934.2008.00385.x. Epub 2008 Jun 28.
本文引用的文献
1
Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.载脂蛋白E与阿尔茨海默病：分子机制与治疗机遇
J Cell Mol Med. 2007 Nov-Dec;11(6):1227-38. doi: 10.1111/j.1582-4934.2007.00130.x.
2
Studies on brain volume, Alzheimer-related proteins and cytokines in mice with chronic overexpression of IL-1 receptor antagonist.白细胞介素-1受体拮抗剂慢性过表达小鼠的脑容量、阿尔茨海默病相关蛋白及细胞因子研究
J Cell Mol Med. 2007 Jul-Aug;11(4):810-25. doi: 10.1111/j.1582-4934.2007.00074.x.
3
Looking for novel ways to treat the hallmarks of Alzheimer's disease.寻找治疗阿尔茨海默病特征的新方法。
Expert Opin Investig Drugs. 2007 Aug;16(8):1183-96. doi: 10.1517/13543784.16.8.1183.
4
Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.神经胶质细胞促炎细胞因子上调作为神经退行性疾病的治疗靶点：基于功能和基于靶点的发现方法。
Int Rev Neurobiol. 2007;82:277-96. doi: 10.1016/S0074-7742(07)82015-0.
5
MitoQ--a mitochondria-targeted antioxidant.MitoQ——一种线粒体靶向抗氧化剂。
IDrugs. 2007 Jun;10(6):399-412.
6
Occludin is overexpressed in Alzheimer's disease and vascular dementia.闭合蛋白在阿尔茨海默病和血管性痴呆中过度表达。
J Cell Mol Med. 2007 May-Jun;11(3):569-79. doi: 10.1111/j.1582-4934.2007.00047.x.
7
Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins.阿尔茨海默病：胆固醇、膜筏、类异戊二烯与他汀类药物
J Cell Mol Med. 2007 May-Jun;11(3):383-92. doi: 10.1111/j.1582-4934.2007.00054.x.
8
The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.调节金属生物利用度作为治疗阿尔茨海默病的一种治疗策略。
FEBS J. 2007 Aug;274(15):3775-83. doi: 10.1111/j.1742-4658.2007.05918.x. Epub 2007 Jul 6.
9
A new framework for the diagnosis of Alzheimer's disease.一种用于诊断阿尔茨海默病的新框架。
Lancet Neurol. 2007 Aug;6(8):667-9. doi: 10.1016/S1474-4422(07)70179-5.
10
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.阿尔茨海默病诊断的研究标准：修订NINCDS-ADRDA标准
Lancet Neurol. 2007 Aug;6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3.
Zotero 插件